Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,586 | -43,159 | -29,877 | -18,363 | -6,961 |
| Depreciation Amortization | 2,275 | 5,884 | 3,930 | 2,025 | 811 |
| Accounts receivable | -78 | 11,454 | 12,327 | 9,830 | -3,256 |
| Other Working Capital | -1,474 | 4,591 | 4,824 | 1,268 | -8,832 |
| Other Operating Activity | 1,764 | -6,993 | -9,230 | -4,996 | 6,912 |
| Operating Cash Flow | $-13,099 | $-28,223 | $-18,026 | $-10,236 | $-11,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -262 | -2,241 | -1,711 | -747 | -466 |
| Purchase Sale Intangibles | -90 | -306 | -195 | -117 | -50 |
| Other Investing Activity | -90 | -306 | -195 | -117 | -50 |
| Investing Cash Flow | $-352 | $-2,547 | $-1,906 | $-864 | $-516 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 103 | 30,078 | 30,078 | 30,078 | 30,000 |
| Debt Repayment | -11 | -45,428 | -25,424 | -25,419 | -25,416 |
| Common Stock Issued | 1,876 | 17,440 | 1,067 | 679 | 475 |
| Other Financing Activity | -4,802 | -828 | -96 | -109 | -108 |
| Financing Cash Flow | $-2,834 | $1,262 | $5,625 | $5,229 | $4,951 |
| Beginning Cash Position | 32,798 | 62,306 | 62,306 | 62,306 | 62,306 |
| End Cash Position | 16,513 | 32,798 | 47,999 | 56,435 | 55,415 |
| Net Cash Flow | $-16,285 | $-29,508 | $-14,307 | $-5,871 | $-6,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,099 | -28,223 | -18,026 | -10,236 | -11,326 |
| Capital Expenditure | -262 | -2,241 | -1,711 | -747 | -466 |
| Free Cash Flow | -13,361 | -30,464 | -19,737 | -10,983 | -11,792 |